| Prioritizing the human genome: knowledge management for drug discovery. | |
| | |
MedLine Citation:
|
PMID: 12833662 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
This review covers recent methods to create a manageable subset of drug targets for development by prioritizing novel genes from the Human Genome Project. The ability to organize genomic data into a distinct set of drug discovery assets can be viewed as a form of knowledge management. While bioinformatics systems have been built to manage genomics-based data, the central theme in creating any bioinformatics infrastructure should be organization-specific knowledge management. |
| | |
Authors:
|
James B Golden |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Current opinion in drug discovery & development Volume: 6 ISSN: 1367-6733 ISO Abbreviation: Curr Opin Drug Discov Devel Publication Date: 2003 May |
Date Detail:
|
Created Date: 2003-07-01 Completed Date: 2003-08-14 Revised Date: 2005-11-16 |
Medline Journal Info:
|
Nlm Unique ID: 100887519 Medline TA: Curr Opin Drug Discov Devel Country: England |
Other Details:
|
Languages: eng Pagination: 310-6 Citation Subset: IM |
Affiliation:
|
454 Corporation, 20 Commercial Street, Branford, CT 06405, USA. jgolden@454.com |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Database Management Systems* / standards, trends Drug Delivery Systems / methods, trends Genome, Human* Humans Technology, Pharmaceutical / methods*, standards, trends |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Genome-wide prediction of disease-relevant genes and variants.
Next Document: High-throughput SNP analysis for genetic association studies.